Imagion Biosystems Ltd
ASX:IBX
Prices of ASX stocks are not being updated. The latest IBX price on Alpha Spread is from Oct 14, 2026. Financials, forecasts and intrinsic value keep updating.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Imagion Biosystems Ltd
ASX:IBX
|
AU |
|
L
|
Lime Technologies AB (publ)
F:LTX
|
SE |
|
Dal'nevostochnoye Morskoye Parokhodstvo PAO
MOEX:FESH
|
RU |
|
Prodia Widyahusada Tbk PT
IDX:PRDA
|
ID |
|
L
|
Lloyds Banking Group PLC
XMUN:LLD
|
UK |
|
I
|
Il Seung Co Ltd
KOSDAQ:333430
|
KR |
Intrinsic Value
Is IBX undervalued or overvalued?
See the intrinsic value estimate for Imagion Biosystems Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
IBX looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with IBX’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Imagion Biosystems Does
Imagion Biosystems Ltd. engages in the research and development of non-radioactive and safe diagnostic imaging technology. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-06-22. The firm is developing a non-radioactive and precision diagnostic molecular imaging technology. Its principal activity consists of nanotechnology, biotechnology, cancer diagnostics and medical imaging using magnetic resonance.
- Headquarters
- Australia AU
- IPO date
- Jun 22, 2017
Earnings Waterfall
Imagion Biosystems Ltd
The intrinsic value for Imagion Biosystems Ltd (IBX) under the Base Case is hidden AUD.
Compared with the last price of 0.006 AUD on Oct 14, the stock appears hidden.